Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 7 Leukemia, Myeloid, Acute 6 Breast Neoplasms 6 Colorectal Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Triple Negative Breast Neoplasms 3 Skin Neoplasms 3 Mesothelioma, Malignant 3 Lymphoma, Non-Hodgkin 3 Uveal Melanoma 2 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Sarcoma 2 Recurrence 2 Rectal Neoplasms 2 Pleural Effusion, Malignant 2 Neuroblastoma 2 Neoplasms 2 Multiple Myeloma 2 Lung Neoplasms 2 Leukemia, Myeloid 2 Leukemia 2 Head and Neck Neoplasms 2 Glioblastoma 2 Esophageal Neoplasms 2 Carcinoma, Merkel Cell 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1

Interventions

Magnetic Resonance Spectroscopy 23 Radiosurgery 21 Temozolomide 14 Bevacizumab 12 pembrolizumab 10 Specimen Handling 9 Nivolumab 8 Radiotherapy 7 Ipilimumab 7 Magnetic Resonance Imaging 6 Cyclophosphamide 5 Capecitabine 5 Blood Specimen Collection 5 encorafenib 4 Radiation 4 Neuropsychological Tests 4 Mental Status and Dementia Tests 4 Memantine 4 Carboplatin 4 fludarabine 3 fluciclovine F-18 3 binimetinib 3 abemaciclib 3 Watchful Waiting 3 Proton Therapy 3 Etoposide 3 Dexamethasone 3 Adrenal Cortex Hormones 3 trastuzumab deruxtecan 2 sacituzumab govitecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Brain Neoplasms × Interleukin-2 × Clear all

NCT06640582 2024-11-05

BAH2472

Essen Biotech

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡